Here, we present remarkable epoxyketone-based proteasome inhibitors with low nanomolar in vitro potency for blood-stage Plasmodium falciparum and low cytotoxicity for human cells. Our best compound has more than 2,000-fold greater selectivity for erythrocytic-stage P. falciparum over HepG2 and H460 cells, which is largely driven by the accommodation of the parasite proteasome for a D-amino acid in the P3 position and the preference for a difluorobenzyl group in the P1 position. We isolated the proteasome from P. falciparum cell extracts and determined that the best compound is 171-fold more potent at inhibiting the β5 subunit of P. falciparum proteasome when compared to the same subunit of the human constitutive proteasome. These compounds also significantly reduce parasitemia in a P. berghei mouse infection model and prolong survival of animals by an average of 6 days. The current epoxyketone inhibitors are ideal starting compounds for orally bioavailable anti-malarial drugs.

Calibr a division of The Scripps Research Institute 11119 N Torrey Pines Rd La Jolla California 92093 USA

Center for Marine Biotechnology and Biomedicine Scripps Institution of Oceanography University of California San Diego 9500 Gilman Drive La Jolla California 92093 USA

Department of Pediatrics School of Medicine University of California San Diego 9500 Gilman Drive La Jolla California 92093 USA

Department Pharmaceutical Sciences College of Pharmacy University of Jordan Amman 11942 Jordan

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences 16610 Prague Czech Republic

Skaggs School of Pharmacy and Pharmaceutical Sciences University of California San Diego 9500 Gilman Drive La Jolla California 92093 USA

000      

00000naa a2200000 a 4500

001      

bmc23010480

003      

CZ-PrNML

005      

20230801132443.0

007      

ta

008      

230718s2023 gw f 000 0|eng||

009      

AR

024    7_

$a 10.1002/chem.202203958 $2 doi

035    __

$a (PubMed)36617500

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a gw

100    1_

$a Almaliti, Jehad $u Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $u Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $u Department Pharmaceutical Sciences, College of Pharmacy, University of Jordan, Amman, 11942, Jordan $1 https://orcid.org/0000000235620846

245    10

$a Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome Inhibitors / $c J. Almaliti, P. Fajtová, J. Calla, GM. LaMonte, M. Feng, F. Rocamora, S. Ottilie, E. Glukhov, E. Boura, RT. Suhandynata, JD. Momper, MK. Gilson, EA. Winzeler, WH. Gerwick, AJ. O'Donoghue

520    9_

$a Here, we present remarkable epoxyketone-based proteasome inhibitors with low nanomolar in vitro potency for blood-stage Plasmodium falciparum and low cytotoxicity for human cells. Our best compound has more than 2,000-fold greater selectivity for erythrocytic-stage P. falciparum over HepG2 and H460 cells, which is largely driven by the accommodation of the parasite proteasome for a D-amino acid in the P3 position and the preference for a difluorobenzyl group in the P1 position. We isolated the proteasome from P. falciparum cell extracts and determined that the best compound is 171-fold more potent at inhibiting the β5 subunit of P. falciparum proteasome when compared to the same subunit of the human constitutive proteasome. These compounds also significantly reduce parasitemia in a P. berghei mouse infection model and prolong survival of animals by an average of 6 days. The current epoxyketone inhibitors are ideal starting compounds for orally bioavailable anti-malarial drugs.

650    _2

$a myši $7 D051379

650    _2

$a zvířata $7 D000818

650    _2

$a lidé $7 D006801

650    _2

$a inhibitory proteasomu $x chemie $7 D061988

650    _2

$a proteasomový endopeptidasový komplex $x chemie $7 D046988

650    12

$a Plasmodium $7 D010961

650    _2

$a Plasmodium falciparum $7 D010963

650    12

$a antimalarika $x farmakologie $7 D000962

655    _2

$a časopisecké články $7 D016428

700    1_

$a Fajtová, Pavla $u Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610, Prague, Czech Republic $1 https://orcid.org/0000000240290706

700    1_

$a Calla, Jaeson $u Department of Pediatrics, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000348123168

700    1_

$a LaMonte, Gregory M $u Department of Pediatrics, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000260364063

700    1_

$a Feng, Mudong $u Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000316860454

700    1_

$a Rocamora, Frances $u Department of Pediatrics, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000225796733

700    1_

$a Ottilie, Sabine $u Department of Pediatrics, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $u Calibr, a division of The Scripps Research Institute, 11119 N Torrey Pines Rd, La Jolla, California, 92093, USA $1 https://orcid.org/0000000197972612

700    1_

$a Glukhov, Evgenia $u Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000165139909

700    1_

$a Boura, Evzen $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610, Prague, Czech Republic $1 https://orcid.org/0000000296524065

700    1_

$a Suhandynata, Raymond T $u Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000247677639

700    1_

$a Momper, Jeremiah D $u Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000231546685

700    1_

$a Gilson, Michael K $u Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000233751738

700    1_

$a Winzeler, Elizabeth A $u Department of Pediatrics, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000240492113

700    1_

$a Gerwick, William H $u Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $u Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000314034458

700    1_

$a O'Donoghue, Anthony J $u Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA $1 https://orcid.org/0000000156950409

773    0_

$w MED00004916 $t Chemistry (Weinheim an der Bergstrasse, Germany) $x 1521-3765 $g Roč. 29, č. 20 (2023), s. e202203958

856    41

$u https://pubmed.ncbi.nlm.nih.gov/36617500 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20230718 $b ABA008

991    __

$a 20230801132440 $b ABA008

999    __

$a ok $b bmc $g 1963104 $s 1196745

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 29 $c 20 $d e202203958 $e 20230306 $i 1521-3765 $m Chemistry $n Chemistry $x MED00004916

GRA    __

$a INV-037899 $p Bill & Melinda Gates Foundation $2 United States

GRA    __

$a R01AI158612 $p NIH HHS $2 United States

GRA    __

$a R21AI133393 $p NIH HHS $2 United States

GRA    __

$a R21AI146387 $p NIH HHS $2 United States

GRA    __

$a R21AI171824 $p NIH HHS $2 United States

GRA    __

$a INV-037899 $p Bill & Melinda Gates Foundation $2 United States

GRA    __

$a R01AI158612 $p NIH HHS $2 United States

GRA    __

$a R21AI133393 $p NIH HHS $2 United States

GRA    __

$a R21AI146387 $p NIH HHS $2 United States

GRA    __

$a R21AI171824 $p NIH HHS $2 United States

GRA    __

$a R01GM061300 $p NIH HHS $2 United States

GRA    __

$a 940892 $p St. Baldrick's Foundation

LZP    __

$a Pubmed-20230718